Shield Therapeutics revenues boosted by US sales of iron deficiency pills The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market Birmingham Post · Feb 9, 2023
North East deals of the week: key investments, contracts and acquisitions Companies involved in deals this week include Mobile Mini, Cascade Cash Management and Ben Johnson Ltd Birmingham Post · Dec 20, 2022
Gateshead's Shield Therapeutics says US expansion will be aided by new shelf life ruling The company launched its lead drug Accrufer in the US last year Birmingham Post · Oct 27, 2022
Losses widen at Shield Therapeutics though sales and prescriptions of its drugs grow The maker of iron deficiency tablets says there is a huge unmet need for its products in the US were about 20 million people suffer anaemia Birmingham Post · Sep 8, 2022
Shield Therapeutics finalises $10m loan agreement from cornerstone shareholder 'Shield is fortunate to be able to count on continued support by an established pharmaceutical company like AOP' Birmingham Post · Aug 1, 2022